Thomas J. Lynch Jr. - 27 Oct 2022 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Director
Signature
/s /Allan Reine, M.D., Attorney-in-Fact
Issuer symbol
FHTX
Transactions as of
27 Oct 2022
Net transactions value
+$263,360
Form type
4
Filing time
31 Oct 2022, 16:04:18 UTC
Next filing
22 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Options (Right to buy) Award $263,360 +32,000 $8.23 32,000 27 Oct 2022 Common Stock 32,000 $8.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest as to one-third of the underlying shares of common stock on each of the first three anniversaries of the date of grant, subject to the recipient's continuing service on the board of directors.